ClinicalTrials.Veeva

Menu

Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia

M

Mansoura University

Status and phase

Completed
Phase 4

Conditions

Mesenteric Ischemia

Treatments

Drug: Heparin injection

Study type

Interventional

Funder types

Other

Identifiers

NCT02645240
mansoura30

Details and patient eligibility

About

The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.

Full description

The study aims to identify several clinical, laboratory, and radiologic factors that can accurately predict the occurrence of intestinal infraction in patients with mesenteric vascular occlusion or ischemia in order to prevent unnecessary surgical intervention in patients with just intestinal ischemia and to hasten intervention in patients with actual intestinal gangrene.

Enrollment

97 patients

Sex

All

Ages

16 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute mesenteric Ischemia

Exclusion criteria

  • Patients with other causes of acute abdomen other than mesenteric Ischemia

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

97 participants in 1 patient group

Heparin injection
Experimental group
Description:
Injection of low molecular weight heparin in patients with acute mesenteric ischemia to assess outcome
Treatment:
Drug: Heparin injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems